Phase 1 Mild Cognitive Impairment (MCI) Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Biomarker-based Trial of NPC-1 for Alzheimer's Pathology

Alzheimer DiseaseMild Cognitive Impairment (MCI)Subjective Cognitive Complaints (SCCs)

Massachusetts General Hospital40 enrolled1 locationNCT07236190

Recruiting

Phase 1

Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study

Mild Cognitive Impairment (MCI)Alzheimer Dementia (AD)

National University Hospital, Singapore48 enrolled1 locationNCT07210528